| Stage | AVGO | % of rev | VRTX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $29.6B | 100.00% | $3.3B | 100.00% | AVGO ×8.88 |
| Gross profit | $20.5B | 69.13% | $2.8B | 85.33% | VRTX +16.2pp |
| Operating income | $16.0B | 53.92% | $1.2B | 37.40% | AVGO +16.5pp |
| Pre-tax income | $15.3B | 51.62% | $1.4B | 41.75% | AVGO +9.9pp |
| Net income | $13.1B | 44.23% | $1.1B | 32.99% | AVGO +11.2pp |
| Stage | AVGO | VRTX | Gap · A − B |
|---|---|---|---|
| Revenue | $29.6B100.00% | $3.3B100.00% | AVGO ×8.88 |
| Gross profit | 69.13%$20.5B | 85.33%$2.8B | VRTX +16.2pp |
| Operating income | 53.92%$16.0B | 37.40%$1.2B | AVGO +16.5pp |
| Pre-tax income | 51.62%$15.3B | 41.75%$1.4B | AVGO +9.9pp |
| Net income |
| 44.23%$13.1B |
| 32.99%$1.1B |
| AVGO +11.2pp |
No shared counterparties.